Stay updated on Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The site revision label was updated from v3.4.3 to v3.5.0. No visible changes to study details or page content were observed.
    Difference
    0.1%
    Check dated 2026-03-18T20:29:13.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T19:01:44.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the prior Revision: v3.4.1 entry and the funding-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:50:51.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added a site-wide notice about the government funding lapse and NIH Clinical Center status, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:29:33.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added UI elements and metadata labels (glossary, Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) along with No FEAR Act Data and Revision: v3.4.0; removed corresponding older items (Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data) and older revision reference (Revision: v3.3.4).
    Difference
    0.3%
    Check dated 2026-01-28T06:08:27.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is displayed, replacing the previous v3.3.3. This appears to be a minor version update with no visible changes to study details or page functionality.
    Difference
    0.1%
    Check dated 2026-01-14T02:44:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.